APA

Koutsilieris M., Mitsiades C. & Sourla A. (20000906). Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. : Molecular medicine (Cambridge, Mass.).

Chicago

Koutsilieris M, Mitsiades C and Sourla A. 20000906. Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. : Molecular medicine (Cambridge, Mass.).

Harvard

Koutsilieris M., Mitsiades C. and Sourla A. (20000906). Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. : Molecular medicine (Cambridge, Mass.).

MLA

Koutsilieris M, Mitsiades C and Sourla A. Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. : Molecular medicine (Cambridge, Mass.). 20000906.